Abstract: Magnetic resonance enterography (MRE) is a leading radiological modality in Crohn's disease (CD) and is used together with laboratory findings and endoscopic examinations for the evaluation of patients during initial diagnosis and follow up. Over the years, there has been great progress in the understanding of CD and there is a continuous strive to achieve better monitoring of patients and to develop new modalities which will predict disease course and thus help in clinical decisions making. An objective evaluation of CD using a quantification score is not a new concept and there are different clinical, endoscopies, radiological and combined indices which are used in clinical practice. Such scores are a necessity in clinical trials on CD for evaluation of disease response, however, there is no consensus of the preferred MRE score and they are not routinely used. This review presents MRE-based indices in use in the last decade: the Magnetic Resonance Index of Activity (MaRIA), the Clermont score, the Crohn's Disease Magnetic Resonance Imaging (MRI) Index (CDMI), the Magnetic Resonance Enterography Global Score (MEGS) and the Lemann index. We compare the different indices and evaluate the clinical research that utilized them. The aim of this review is to provide a reference guide for researchers and clinicians who incorporate MRE indices in their work. When devising future indices, accumulated data of the existing indices must be taken into account, as each of the current indices has its own strengths and weakness.
Introduction
Crohn's disease (CD) is a chronic inflammatory disease of the bowel wall and can affect any part of the gastrointestinal (GI) tract. The disease is characterized by recurrent relapses and cause great impairment to a patient's life. During the course of the disease significant complications such as strictures, abscess or fistula can occur. 1 Management of the disease was once solely based on patients' symptoms. In recent years, there was a change in concept and new therapeutic goals have emerged. 2, 3 Considerable efforts are being taken to achieve mucosal healing which is considered one of the best therapeutic endpoints in CD, as it is associated with sustained clinical remission, reduced rates of hospitalization and decreased risk of surgery. [4] [5] [6] Thus, monitoring of patients requires closer follow up and frequent evaluations.
Because CD is known as a transmural disease and assessing the mucosal lining may not reflect the true extent of the disease, the importance of transmural healing is being evaluated these days. 7 Radiological assessment is important when assessing transmural involvement, as endoscopy is limited to the assessment of the mucosa.
To date, ileocolonoscopy remains the reference standard for evaluation of disease activity in CD. However, it's an invasive procedure with low tolerability by the patient and allows visualization of the mucosal surface only without assessing extraluminal complications. Furthermore, many of CD patients have disease restricted to the small bowel which is not visualized well by conventional endoscopy.
Magnetic resonance enterography (MRE) has become one of the prime modalities for the assessment of CD. 8 Many studies have focused on developing indices for quantification of active disease which will help in guidance of patients' therapy. MRE indices serve as a disease quantification tool and thus may help standardize measured outcomes in clinical trials of treatment interventions for CD. In addition, these indices may be used in academic research and when validated may provide a quantified clinical decision tool for estimating mucosal healing.
The aim of our study is to introduce the major and most recent MRE-based scores for quantification of active CD patients.
Search strategy and study selections
This is a review article and therefore ethics approval and informed consent were not required for this review.
An extensive literature search of the PubMed database encompassing a period of the preceding 10 years (January 2008-September 2017) was performed.
In order to find all relevant citations, the following combination of Mesh terms or keywords was applied: ('score' OR 'scores' OR 'indices' OR 'index') AND ('magnetic resonance enterography' OR 'MR enterography' OR 'MRE' OR 'magnetic resonance imaging' OR 'MR imaging' OR 'MRI') AND ('crohn's disease' OR 'crohn disease'). The search was restricted to articles in the English language.
Studies were selected using a few-steps process: we first scanned all headlines and abstracts and excluded articles that did not meet the following inclusion criteria: 1) MRE or magnetic resonance enteroclysis were the performed radiologic modalities 2) Only CD patients were included
In our review we chose to describe only MRE indices which are currently at the center of research. Therefore, for an index to be included it must have been investigated by more than one research group except for the original developing group. Other indices were excluded [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] ( Figure  1 ). Finally, five indices were included in this review; the Magnetic Resonance Index of Activity (MaRIA), the Clermont score, the Crohn's Disease Magnetic Resonance Imaging (MRI) Index (CDMI), the Magnetic Resonance Enterography Global Score (MEGS) and the Lemann index. The methodology of their designing studies is specified in Table 1 and the MRE parameters included in each of the indices is detailed in Table 2 .
An Institutional Review Board approval was granted for presentation of the MRE images included in this review.
Magnetic resonance index of activity (MaRIA)
Rimola and colleagues 26 were the first to develop an MRE-based index for quantification of disease activity. Their reference standard was ileocolonoscopy and its derived CD endoscopic index of severity (CDEIS). They evaluated six bowel segments; the distal ileum, ascending, transverse, descending, sigmoid colon and rectum. Several MRE features were studied for each segment while the final score was based only on the features which were found to be independent predictors for endoscopic active disease; Bowel wall thickness (mm), ulcers, edema (defined as hyperintensity of the bowel wall relative to the signal of the psoas muscle on T2-wedged sequence), measurements of wall signal intensity (WSI) before and after intravenous (IV) contrast administration and relative contrast enhancement (RCE) of the intestinal wall. WSI is calculated by the average of three wall enhancement measurements. RCE is calculated by the following formula: RCE = [(WSI postgadolinium−WSI pregadolinium)/(WSI pregadolinium)] × 100 × [standard deviation (SD) noise pregadolinium/SD noise postgadolinium], where SD noise pre and postgadolinium is calculated by the average of three SDs of the signal intensity measured outside of the body before and after gadolinium injection, respectively. The simplified (= segmental) MaRIA score is represented by the following formula:
1.5 × wall thickness (mm) + 0.02 × RCE + 5 × edema + 10 × ulceration.
The simplified MaRIA score had a high (r = 0.81) and significant (p < 0.001) correlation with the CDEIS of the correspondent segment.
A global MaRIA score is calculated by adding the values of all six bowel segments. It showed significant correlation with CDEIS (r = 0.78, p < 0.001), Harvey-Bradshaw index (r = 0.56, p < 0.001) and c-reactive protein (CRP) (r = 0.53, p < 0.001).
In an external validation of their previous study, Rimola and colleagues 32 established cutoff points for disease severities (Table 3) . Active disease was defined as endoscopic lesions of any severity and severe disease was defined as deep or superficial ulcerations at endoscopy. 32 Diffusion-weighted imaging (DWI) is an imaging technique which derives its signal contrast from the Brownian motion of water molecules. In the extracellular space, water molecules move relatively free while in the intracellular compartment their movement is restricted. Pathological processes change the proportion of the intra and extracellular water molecules and thus effect the tissue's diffusion properties. The intensity of DWI allows qualitative assessment whereas generation of apparent diffusion coefficient (ADC) map from DWI acquisition allows quantitative measurements. 33 DWI was first used in neurology where patients with stroke demonstrated hyperintensity and low ADC values. 34, 35 Oto and colleagues 36 were the first to evaluate the role of DWI and ADC in detection of bowel inflammation and demonstrated that inflamed segments have an increased signal and lower ADC values. This observation was confirmed by other studies 37 and the use of DWI in CD continues to develop. 38, 39 With the increasing use of DWI in radiological evaluation of disease activity Kim and colleagues 40 proposed recently a modifying MRE index which replaces ulcers with DWI grading. Buisson and colleagues 27 developed the first index which combines DWI and ADC measurements ( Figure 5 ). The ileum was the only segment to be evaluated. By using the MaRIA score as a reference standard they developed the Clermont score, a DWI-based index for quantification of disease activity, which combined conventional MRE parameters derived by the MaRIA index.
Calculation is performed by the following formula:
An external validation by the same group was later performed. 41 The Clermont score was found to be highly correlated with the MaRIA score (rho = 0.99) in ileal CD but not in colonic CD (rho < 0.8). A Clermont score >8.4 was found to be predictive of active ileal disease which was defined as MaRIA ⩾ 7 (receiver operating characteristic curve (ROC) of 0.99, p = 0.0001) and a score ⩾12.5 was found to be predictive of severe ileal disease (MaRIA ⩾ 11) ( Table 3 ). 
Crohn's disease MRI index (CDMI) and MEGS
The MEGS is based on a previously proposed CDMI score 28 and was developed in order to better evaluate full disease burden. CDMI used pathology as a reference standard. Few specimens were taken from a surgically removed terminal ileum and were assigned an endoscopic biopsy acute inflammation score (AIS). Using a postoperative MRE of the resected segment, the specimen locations were allocated on an MRE performed prior to surgery. The MRE was evaluated according to the following parameters: mural thickness, mural T2 signal, perimural T2 signal, mural enhancement pattern, degree of enhancement, lymph nodes and lymph nodes enhancement. Only mural thickness and mural T2 signal showed correlation in a univariable, multivariable and backward selection and therefore were the only parameters included in the final formula:
journals.sagepub.com/home/tag 5 The two additional parameters, contrast enhancement and perimural T2 signal, demonstrated only a univariable correlation to AIS. The simple sum of all four parameters slightly improved the correlation to endoscopic score in comparison with the proposed model and is the preferred method between the two.
Makanyanga and colleagues 29 used the same variables previously described in the basic index and in an attempt to better reflect the true extent of the disease suggested few modifications. The final MEGS score, divides the GI tract to nine segments and its full description and calculation is depicted in Table 4 
Lemann index
The Lemann index differs from other indices by assessing structural damage rather than the extent of disease activity and mucosal inflammation. 30, 31 The Leman score is a bowel damage score not a bowel activity score. The GI tract is divided into four parts which are further divided into segments: upper tract (esophagus, stomach, duodenum), small bowel (each segment is 20 cm), colon (cecum, ascending/transverse/ descending and sigmoid colon, rectum) and anus. Each of the segments is evaluated according to three parameters: surgical intervention, stricturing lesions and penetrating lesions which are being evaluated by either endoscopy, colonoscopy, computed tomography or MRI and are graded between 0-3 ( Figure 6 ). All of the data are entered into a Microsoft Excel-based calculator provided by the LI score study group. when taking into account disease duration which emphasizes its significant as indicator of long term damage which is not affected by acute flares.
Validation of the indices
Revalidation of the indices was performed by the studies presented in Table 6 . The validating studies have shown variable results for the ability of the indices to detect active disease. However, there is a great inconsistency between the validating studies methods, gold standards and evaluated bowel segment which makes it difficult to draw any conclusion regarding the capacity of these indices to reflect disease activity.
Interobserver studies
Evaluating the score's precision is crucial prior to its implantation in clinical practice. The results of the score must be repeatable in order to be used as a reliable clinical tool. Tielbeek and colleagues 51 Studies performed in children do not rely on endoscopy as a reference standard due to its invasiveness. Instead, the pediatric CD activity index (PCDAI), which includes the patient's history, findings in physical examination and laboratory values is used. Pomerri and colleagues 53 were the first to investigate the accuracy of these indices in the young population of patients. The global MaRIA and MEGS revealed a weak-to-moderate correlation to the PCDAI (r = 0.42, p = 0.016 and r = 0.46, p = 0.007, respectively). 
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Clinical implications of MRE indices

Response to therapy and mucosal healing
Response to therapy is an important element of patient monitoring and decision making. The primary goal is to achieve mucosal healing; however, it is a demanding task considering the repeated endoscopies it requires. MRE plays a significant role in CD management but its ability to monitor treatment responsiveness is yet to be determined. Table 7 demonstrates the studies which tried to elucidate this point.
Ordas and colleagues 57 examined the ability of MaRIA to identify ulcer healing following treatment and the accuracy of MaRIA to assess mucosal healing (CDEIS < 3.5). The diagnostic accuracy of MaRIA to predict ulcer healing (MaRIA < 11) was 90% and to predict mucosal healing (MaRIA < 7) was 83%. The MaRIA score demonstrated high responsiveness for therapy-induced changes and proves to be a reliable tool to assess response to therapy. Similarly, Stoppino and colleagues 55 also evaluated the responsiveness of MaRIA to treatment with anti-tumor necrosis factor (TNF) and its correlation to endoscopic appearance. They found a significant change in the MaRIA value before and after treatment and a significant correlation with the simple endoscopic activity score for CD (SES-CD).
Prezzi and colleagues 56 characterized the response of MEGS to anti-TNFα therapy, however, they used clinical disease activity as a reference standard which does not truly reflect disease activity. MEGS significantly changed in clinically responders to therapy but not in nonresponders and a moderate correlation was observed with clinical activity. Another aspect of response to therapy was investigated by Tielbeek and colleagues 58 who assessed the ability of MRE to reflect changes of anti-TNF on transmural inflammation and stenotic lesions. It their study, CDMI was able to reflect responsiveness on both aspects, since a significant improvement in score was observed in the responding segments but not in the nonresponding segments (transmural inflammation: 5.19 to 3.12, p < 0.0001 versus 5.55 to 5.92, p = 0.49; stenotic segments: 6.33 to 4.58, p = 0.01 versus 6.61 to 6.72, p = 0.79).
Moy and colleagues 59 reassured previous results, however, their study differ in design and goals and did not assess MRE response to therapy but rather the ability to detect mucosal healing. Ye and colleagues 44 determined a cutoff value of 6.8 for detection of mucosal healing [area under the curve (AUC) 0.881, sensitivity 100%, specificity 79.2%] however they used a different value of SES-CD for mucosal healing as a standard reference.
Buisson and colleagues 60 have recently compared the ability of MaRIA and Clermont to detect mucosal ulceration and predict mucosal healing using endoscopy as a reference standard. Both indices were equally effective in detecting endoscopic ulceration with specificity (82.1% and 81.3%, respectively) and substantially negative predicting value (82.1% and 82.4%, respectively) while the sensitivity and positive predicting value were moderate
An emerging clinical concept these days is transmural healing, which refers to normalization of both radiologic scans and endoscopy examinations. 7, 61 Its rate, effect on disease course and methods for evaluation are being assessed and the role of MRE-based indices is still unknown.
MRE indices as prognostic tools
Biological therapy with anti-TNF antibodies is widely used for inducing and maintaining remission. Some patients develop resistance to therapy after initial response and clinical remission and it is necessary to evaluate the extent of disease for planning treatment strategy. Naganuma and colleagues 62 studied a cohort of 50 patients who have finished therapy with anti-TNF drugs and during a period of up to 3 years observed for clinical flares. They aimed to discover whether MRE can predict prognosis of patients with an initial clinical remission. The MaRIA score was not found to be correlated with an increased risk to abdominal resection surgery in a study conducted by Amezaga and colleagues. 63 Both groups of patients, the group who did not need surgery and the one who did, demonstrated similar scores (65 and 62, respectively, p = 0.6). The significant of this observation is that the severity of a particular flare, measured by a validated MRI index, is not a predictor of the need for abdominal surgical resection. Bodini and colleagues 68 studied the efficacy of several treatment modalities in preventing bowel damage progression as assessed by Lemann index. They found anti-TNF to be superior to that of azathioprine and mesalazine as it was able to maintain a stable LI.
Evaluation of bowel damage in CD
Capsule endoscopy
Capsule endoscopy overcomes few of the major disadvantages of standard ileocolonoscopy and allows visualization of the small bowel in a noninvasive method. It is now considered a standard tool in the evaluation of CD patients [69] [70] [71] Each of the models reviewed in this article entails some advantages over the others and at the same time carries some drawbacks which make it less favorable. Validating studies have shown inconsistences regarding the accuracies of each models, and there is much room for further research expanding current data. Getting familiar with the pros and cons of the current models is important The MaRIA is the most studied index and offers an extensive data of its performance against different investigating modalities (clinical scores, pathology, conventional endoscopy, video capsule endoscopy, inflammatory biomarkers). Therefore, it may be considered for use as a reference index these days.
The Clermont score incorporates the DWI technique which has been well integrated into many radiological fields and showed a very strong correlation to MaRIA (r = 0.99). A limitation of the Clermont score is that it is the only one of the five scores without truly independent validation with another modality. It contains many similar items to the MaRIA score so it is not surprising the two scores correlate well. It can be used when there is a decision not to inject contrast material and we believe it will gain more popularity with the increasing use of DWI in CD imaging. The CDMI is an index that has not been studied much but offers a relatively simple method of calculation, with few investigated variables, and should therefore be considered when saving time is of interest.
The MEGS lacks pathological validation but on the other hand is correlated with clinical score of disease activity, stool and blood markers. It has the advantages of evaluating the entire small bowel and incorporating extra-intestinal findings and should be used as a tool for evaluating the extent of the disease. Of note is that the MEGS score is complicated to obtain, due to its large number of variables (see Table 3 ).
The Lemann index is specifically targeted for measuring cumulative damage of the intestine and requires the use of a number of modalities other than MRE, which can limit its application.
Distinguishing inflammatory from fibrotic lesions is important in patients' management as it has an impact on treatment choice. 83 None of the current indices was evaluated in this aspect and further studies are required to examine if they are able to make this separation or whether new indices are required. benefit from a larger cohort of patients that will reflect the variability of CD and strength the statistical significance of the multivariate regression analysis.
Conclusion
The observation that patients with endoscopically severe inflammation may still be asymptomatic led to shift in the treatment goal of CD from achieving clinical remission to achieving mucosal healing. 84 This change of treatment paradigm requires a more comprehensive evaluation and higher frequency of testing and thus new tools were introduced into clinical practice in order to better manage CD patients. 85 MRE gained great popularity over the years and is considered one of the gold standards for the diagnosis and follow up of CD. 86 In this review we present and analyze the leading MRE indices from the last 10 years, compare the different indices and evaluate clinical research that utilized them. The aim of this review is to provide a reference guide for researchers and clinicians who incorporate MRE indices in their work. When devising future indices, accumulated data from the existing indices must be taken into account, as each of the current indices has its own strengths and weakness.
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